Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,882,838
  • Shares Outstanding, K 41,110
  • Annual Sales, $ 286,630 K
  • Annual Income, $ -42,610 K
  • 36-Month Beta 1.65
  • Price/Sales 6.57
  • Price/Cash Flow 769.23
  • Price/Book 6.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.03
  • Number of Estimates 6
  • High Estimate 0.14
  • Low Estimate -0.17
  • Prior Year 0.18
  • Growth Rate Est. (year over year) -83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.66 +1.34%
on 12/10/18
50.30 -10.02%
on 12/04/18
-2.28 (-4.80%)
since 11/14/18
3-Month
43.58 +3.85%
on 10/12/18
55.00 -17.71%
on 11/02/18
-1.29 (-2.77%)
since 09/14/18
52-Week
26.95 +67.94%
on 04/02/18
55.00 -17.71%
on 11/02/18
+0.56 (+1.25%)
since 12/14/17

Most Recent Stories

More News
New Retrospective Analysis Demonstrates Significant Reductions in Postsurgical Pain and Opioid Requirements with EXPAREL in Cesarean Section Patients

Results show incorporating transversus abdominis plane block with EXPAREL results in significantly improved patient functional recovery and hospital throughput

PCRX : 45.26 (-1.18%)
Zacks.com featured highlights include: Abercrombie & Fitch, Pacira Pharmaceuticals, Penumbra, Sprint and Salesforce.com

Zacks.com featured highlights include: Abercrombie & Fitch, Pacira Pharmaceuticals, Penumbra, Sprint and Salesforce.com

S : 5.97 (-1.65%)
PEN : 125.40 (-0.74%)
ANF : 18.90 (+0.53%)
PCRX : 45.26 (-1.18%)
CRM : 137.04 (-2.90%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 22.21 (-4.35%)
NGVC : 17.96 (+0.34%)
STC : 41.17 (-0.58%)
ATUS : 17.67 (-0.56%)
RBA : 32.13 (-0.77%)
MHK : 116.98 (-1.03%)
NVCR : 35.66 (+1.02%)
CVSI : 4.8100 (+2.01%)
AC : 34.54 (+1.32%)
BSX : 35.80 (-3.19%)
HON : 136.44 (-1.71%)
POTND : 0.0200 (+32.45%)
PRTT : 1.7000 (+17.24%)
TARSD : 0.2033 (-1.64%)
NKE : 72.53 (-0.55%)
ROIC : 17.68 (+0.63%)
DGX : 85.48 (-3.24%)
EIX : 59.64 (+0.18%)
GARLF : 0.0800 (-3.03%)
MRNA : 18.32 (-2.35%)
MSPC : 0.0002 (unch)
RYAAY : 72.60 (-1.28%)
BA : 318.75 (-2.06%)
BDC : 42.93 (-3.40%)
BC : 46.58 (-1.25%)
OXFD : 13.93 (-2.99%)
NDAQ : 86.54 (-0.55%)
TTOO : 3.92 (+0.77%)
DMAC : 3.54 (+4.12%)
CMCM : 6.92 (+3.75%)
ALGN : 215.57 (-0.76%)
ABM : 25.90 (-1.56%)
RTN : 169.85 (-1.50%)
IESC : 16.13 (-1.29%)
KIDS : 32.96 (+5.04%)
CYL.VN : 0.145 (-9.38%)
FLIR : 43.12 (-1.78%)
NETC.CN : 0.105 (unch)
SLCA : 11.31 (-1.14%)
BANX : 20.20 (-0.49%)
APOG : 31.95 (-1.39%)
RBBN : 5.37 (-1.83%)
SPLIF : 0.1450 (+0.55%)
SO : 47.33 (-0.46%)
SNWV : 0.3049 (+1.63%)
ACB : 5.86 (+2.63%)
CE : 86.69 (-1.28%)
QILFF : 0.1992 (-29.03%)
QILFD : 0.2331 (-29.98%)
MANH : 45.80 (-1.48%)
MKL : 1,048.58 (-1.19%)
HAL : 29.00 (-3.04%)
LZB : 25.73 (-1.98%)
INTC : 47.86 (-0.89%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,591.91 (-4.01%)
ACHC : 28.93 (-6.86%)
TX : 28.33 (-1.22%)
SRPT : 119.52 (-2.05%)
JOUT : 61.75 (+2.07%)
CCAN : 0.2000 (-5.88%)
OBMP : 0.0115 (+0.88%)
ELY : 16.63 (+0.91%)
DY : 53.92 (-4.24%)
HIPH : 0.0330 (-9.84%)
POTN : 0.1433 (-9.30%)
JWN : 48.61 (-0.74%)
SYF : 24.10 (-0.33%)
AQUA : 9.77 (-2.59%)
NWVCF : 0.9457 (+2.02%)
USYNF : 3.1500 (+5.77%)
EMR : 60.44 (-0.48%)
BXE : 0.56 (-4.27%)
HSY : 107.87 (-1.95%)
EW : 160.13 (-2.32%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.52 (-3.70%)
PSX : 86.83 (-2.25%)
MVIS : 0.56 (unch)
PCI : 21.84 (-2.54%)
PCN : 14.94 (-1.45%)
AVT : 38.76 (-1.47%)
MGNX : 13.69 (-7.25%)
ICBK : 20.44 (-0.78%)
DLR : 114.32 (-0.90%)
RHI : 57.76 (-1.08%)
YVR : 3.07 (+3.72%)
PTY : 15.03 (-1.89%)
PDI : 29.95 (-3.11%)
TNXP : 2.81 (+2.93%)
GBT : 42.24 (-0.87%)
QI.VN : 0.290 (-27.50%)
TSRO : 73.69 (-1.07%)
RHP : 71.36 (-1.76%)
NKTR : 36.51 (-3.92%)
GOOG : 1,042.10 (-1.86%)
JBLU : 16.83 (-2.55%)
IGC : 2.49 (unch)
WBT : 12.26 (-1.05%)
WRY.VN : 0.005 (-66.67%)
SAPIF : 31.0080 (+1.77%)
WSO : 147.43 (-1.44%)
LMT : 287.70 (-1.55%)
CMCSA : 36.34 (-1.14%)
HSDT : 9.93 (-0.60%)
GWRE : 82.80 (-1.83%)
CLGX : 36.33 (-1.76%)
FNSR : 21.75 (-1.76%)
SONS : 7.83 (+2.76%)
DEWM : 0.0021 (+5.00%)
SLG : 89.28 (-0.66%)
UPS : 98.66 (-2.10%)
PFN : 9.44 (-1.87%)
KMB : 117.42 (-0.83%)
ANZ.VN : 0.055 (unch)
TAOP : 1.04 (-3.70%)
NSU : 4.38 (-2.01%)
CBDS : 3.5900 (-11.58%)
CTXS : 109.14 (-1.02%)
PCOM : 10.13 (-3.80%)
HTHT : 29.90 (-2.54%)
MAN : 68.38 (-1.38%)
CNK : 40.29 (-0.44%)
AMAT : 32.65 (-3.14%)
FMCC : 1.1300 (unch)
MRK : 76.48 (-3.20%)
ATOS : 1.23 (+3.36%)
WTCRF : 0.0187 (+16.87%)
MLRKF : 0.0712 (+0.14%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 51.35 (-5.47%)
COOL : 17.33 (-0.69%)
SAVE : 59.01 (-2.72%)
PCRX : 45.26 (-1.18%)
RNLSY : 12.4800 (-2.92%)
COL : 141.04 (-0.42%)
COR : 96.90 (-0.71%)
IDXG : 1.02 (+2.00%)
MCD : 183.29 (-1.68%)
ETST : 0.8910 (+11.37%)
QNIIF : 0.7811 (-2.06%)
PII : 79.35 (-0.94%)
AMRS : 4.09 (-2.85%)
SON : 56.00 (-0.16%)
MCK : 116.66 (-5.05%)
APHA : 5.60 (+7.07%)
MCO : 145.52 (-2.30%)
GSKY : 8.66 (-3.24%)
LH : 137.41 (-1.65%)
SAP.TO : 40.85 (-0.49%)
ODFL : 123.43 (-2.44%)
NEU : 394.11 (-0.06%)
ORTX : 14.56 (-2.93%)
BXE.TO : 0.72 (-6.49%)
GWPRF : 10.0500 (+0.23%)
PZN : 9.56 (+1.16%)
RBX.VN : 0.085 (+13.33%)
RNG : 82.47 (-3.17%)
SPG : 182.66 (-0.76%)
TRVN : 0.58 (-4.92%)
AMC : 14.51 (-2.36%)
UTX : 118.80 (-0.38%)
AMD : 19.90 (+0.20%)
NDLS : 6.95 (-5.44%)
MPWR : 118.62 (-2.17%)
KGKG : 0.0990 (+9.88%)
FRO-UN.VN : 0.530 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 18.18 (-1.89%)
IQST : 1.2000 (+18.81%)
ASPS : 21.46 (-3.16%)
HMNY : 0.02 (unch)
ROP : 273.84 (-2.62%)
GOVB : 14.2000 (-8.09%)
PKO : 24.72 (-3.36%)
MYGN : 31.15 (-0.32%)
CRL : 124.96 (-2.31%)
GLPH : 0.0300 (-31.82%)
BXXRF : 0.0200 (unch)
ADTN : 11.52 (-2.29%)
GRNH : 0.0207 (-8.00%)
NS : 24.08 (-1.27%)
LTS : 2.58 (-4.09%)
INT : 22.38 (-2.82%)
INPX : 3.17 (-2.91%)
GSPT : 0.1200 (unch)
MRO.VN : 0.080 (-11.11%)
COST : 207.06 (-8.59%)
EFX : 97.18 (+0.06%)
BMRN : 93.11 (-0.83%)
SPGI : 166.62 (-1.72%)
IGCC : 0.6410 (-2.88%)
PYPL : 85.92 (-1.87%)
LHSIF : 0.7500 (-1.26%)
TDY : 205.31 (+0.59%)
AZPN : 83.19 (-1.35%)
ENW.VN : 1.250 (+1.63%)
DMA.VN : 4.700 (+3.30%)
SNAP : 5.92 (+1.02%)
KSU : 96.67 (-0.49%)
MERC : 11.37 (+1.16%)
DVA : 58.02 (-2.32%)
UNI.VN : 4.200 (-0.94%)
MGI : 1.88 (-1.05%)
IGAP : 0.1500 (+7.14%)
FIT : 4.90 (+2.30%)
RAD : 0.89 (-1.54%)
LDSR : 0.0033 (-2.94%)
CYLYF : 0.1100 (-8.33%)
PMX : 11.05 (-2.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 27.62 (-0.29%)
In Search of an Earnings Beat? Play These Top 5 Stocks

These top-ranked stocks may surpass bottom-line estimates in their next release.

S : 5.97 (-1.65%)
PEN : 125.40 (-0.74%)
ANF : 18.90 (+0.53%)
PCRX : 45.26 (-1.18%)
CRM : 137.04 (-2.90%)
Why Is Pacira (PCRX) Down 7.3% Since Last Earnings Report?

Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX : 45.26 (-1.18%)
Lilly (LLY) Hits Fresh High: Is There Still Room to Run?

Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

RDY : 36.61 (+0.03%)
LLY : 111.93 (-2.55%)
PCRX : 45.26 (-1.18%)
BMY : 52.12 (-2.83%)
New Data Show EXPAREL Plays a Key Role in Achieving Significant Reductions in Opioid Use, Hospital Stay and Total Hospitalization Costs Following Painful Knee Replacement Surgery

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced new data on the use of EXPAREL(R) (bupivacaine liposome injectable suspension) to manage postsurgical pain following total knee arthroplasty...

PCRX : 45.26 (-1.18%)
SmarTrend Watching for Potential Pullback in Shares of Pacira Pharmaceu After 1.05% Gain

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $46.10 to a high of $47.58. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high...

PCRX : 45.26 (-1.18%)
Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Chief Medical Officer Richard Scranton, M.D., M.P.H., was one of three industry representatives invited to provide insight and perspective...

PCRX : 45.26 (-1.18%)
Report: Developing Opportunities within Rayonier Advanced Materials, Health Insurance Innovations, Columbus McKinnon, A. O. Smith, Pacira Pharmaceuticals, and Altice -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Rayonier Advanced Materials...

RYAM : 11.55 (+0.35%)
AOS : 41.41 (-1.96%)
HIIQ : 29.26 (-18.31%)
CMCO : 30.53 (-2.96%)
PCRX : 45.26 (-1.18%)
ATUS : 17.67 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade PCRX with:

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

2nd Resistance Point 46.20
1st Resistance Point 45.73
Last Price 45.26
1st Support Level 44.79
2nd Support Level 44.32

See More

52-Week High 55.00
Last Price 45.26
Fibonacci 61.8% 44.28
Fibonacci 50% 40.97
Fibonacci 38.2% 37.67
52-Week Low 26.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar